Whiteford HA, Ferrari AJ, Degenhardt L, Feigin V, Vos T. The global burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010. PLoS One. 2015;10(2):e0116820.
PubMed Central
PubMed
Article
Google Scholar
Rao D, Choi S, Victorson D, Bode R, Peterman A, Heinemann A, et al. Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Qual Life Res. 2009;18(5):585–95.
PubMed Central
PubMed
Article
Google Scholar
Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet. 2013;380(9859):2055–8.
Article
Google Scholar
Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the “common” neurologic disorders? Neurology. 2007;68(5):326–37.
CAS
PubMed
Article
Google Scholar
Albert SM. Projecting neurologic disease burden: difficult but critical. Neurology. 2007;68(5):322–3.
PubMed
Article
Google Scholar
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2013;380(9859):2163–96.
Article
Google Scholar
Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG. Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med. 2010;8:24 Epub 2010/04/28.
PubMed Central
PubMed
Article
Google Scholar
Feigin V, Kurtzke JF, Korczyn A, Beghi E, Brown A. Bridging the gap between experimental and non-experimental neuroepidemiology, and ultimately—between neuroepidemiological research and practice: round table discussion at the First International Congress on Clinical Neurology and Epidemiology. Neuroepidemiology. 2009;33(4):296–304.
PubMed
Article
Google Scholar
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010;1(2):100–7.
PubMed Central
PubMed
Article
Google Scholar
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
PubMed Central
PubMed
Article
Google Scholar
Oermann MH. SQUIRE guidelines for reporting improvement studies in healthcare: implications for nursing publications. J Nurs Care Qual. 2009;24(2):91–5.
PubMed
Article
Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–8 Epub 2007/10/20.
Article
Google Scholar
Chin JH, Vora N. The global burden of neurologic diseases. Neurology. 2014;83(4):349–51.
PubMed Central
PubMed
Article
Google Scholar
Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195–210 Epub 2013/02/01.
PubMed
Article
Google Scholar
Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord. 2005;20(10):1255–63.
PubMed
Article
Google Scholar
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384–6.
CAS
PubMed
Article
Google Scholar
GBD 2013 Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71.
Article
Google Scholar
Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7(2):e1000217 (Epub 2010/02/20).
PubMed Central
PubMed
Article
Google Scholar
Steurer J. The Delphi method: an efficient procedure to generate knowledge. Skeletal Radiol. 2011;40(8):959–61 Epub 2011/06/15.
PubMed
Article
Google Scholar
Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ. 2012;344:e4178 Epub 2012/06/26.
PubMed Central
PubMed
Article
Google Scholar
Turner L, Shamseer L, Altman D, Schulz K, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa. Syst Rev. 2012;1(1):60.
PubMed Central
PubMed
Article
Google Scholar
Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869 Epub 2010/03/25.
PubMed Central
PubMed
Article
Google Scholar
Altman DG, Simera I, Hoey J, Moher D, Schulz K. EQUATOR: reporting guidelines for health research. Lancet. 2008;371(9619):1149–50 Epub 2008/04/09.
PubMed
Article
Google Scholar
Simera I, Moher D, Hoey J, Schulz KF, Altman DG. The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies. Maturitas. 2009;63(1):4–6 Epub 2009/04/18.
PubMed
Article
Google Scholar
Cialkowska M, Adamowski T, Piotrowski P, Kiejna A. What is the Delphi method? Strengths and shortcomings. Psychiatria polska. 2008;42(1):5–15 (Epub 2008/06/24. Czym jest metoda Delphi? Zalety i ograniczenia).
PubMed
Google Scholar
Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2013;380(9859):2063–6.
Article
Google Scholar